flyweight Sarah Frota will have to sit for the next two years following a positive drug test for steroids.

USADA (United States Anti-Doping Agency), who oversee the ’s anti-doping program, announced the suspension Tuesday.

“Frota Lima, 32, tested positive for multiple stanozolol metabolites, including 16α-hydroxystanozolol, 3’,16-dihydroxystanozolol, and 4β,16-dihydroxystanozolol, as the result of an in-competition urine sample she provided on July 27, 2019 at UFC 240 , where she lost by technical knockout,” USADA officials wrote in the statement.

Stanozolol is a synthetic anabolic steroid that came to prominence in the 1980s when Olympic runner Ben Johnson tested positive for the drug and was later stripped of his gold medal. Several fighters have tested positive for stanozolol in the past including Ruslan Magomedov, who received a lifetime ban from the USADA following multiple infractions of the ’s anti-doping policy.

Frota’s suspension was made retroactive to the date of her test on July 27, which was the night she suffered a second-round TKO loss to Gillian Robertson at 240 in .

The positive drug test also falls under the jurisdiction of the Combative Sports Commission, who accepted the two-year suspension handed down by USADA.

Frota won’t be eligible to compete again until after July 27, 2021. She is currently 0-2 in her campaign including the loss to Robertson as well as a split decision defeat in her Octagon debut.

LEAVE A REPLY

Please enter your comment!
Please enter your name here